Radiko Holdings Corp. Share Price Canadian Securities Exchange
Equities
JUJU
CA75034R1029
Pharmaceuticals
Sales 2018 | 107K 146K 8.37M | Sales 2019 | 5.18M 7.08M 407M | Capitalization | 6.17M 8.43M 485M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.46M -314M | Net income 2019 | -10M -13.66M -786M | EV / Sales 2018 | 101 x |
Net Debt 2018 | 259K 353K 20.32M | Net Debt 2019 | 1.98M 2.71M 156M | EV / Sales 2019 | 1.57 x |
P/E ratio 2018 |
-1.5
x | P/E ratio 2019 |
-0.53
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 96.73% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 15/04/18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 09/12/19 |
Scott Reeves
BRD | Director/Board Member | 55 | 31/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 15/04/18 |
Scott Reeves
BRD | Director/Board Member | 55 | 31/01/17 |
Robert Yosaitis
BRD | Director/Board Member | - | 11/11/19 |
1st Jan change | Capi. | |
---|---|---|
+37.78% | 723B | |
+31.13% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.51% | 244B | |
-4.62% | 208B | |
+10.04% | 210B | |
+9.32% | 169B |